HIV Infection: Research Studies

HIV Infection: Research Studies

HIV Infection: Research Studies (HIRS) is an open access, peer-reviewed journal with broad scope covering all zones of the advanced topics in drug development, HIV vaccines, pre-exposure prophylaxis, Post-exposure prophylaxis, Sex Education, HIV/AIDS Denialism, AIDS Dementia Complex, rural livelihoods, stigma, patient oriented research studies, and other significant new studies related to the field of HIV/AIDS & Clinical Research. Substantial advances in the development of antiretroviral drugs and clinical management are being achieved in the field of HIV and AIDS, although many research challenges remain. In recognition of an increased focus on contemporary clinical challenges and disease management issues.

The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. HIRS aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process. Therefore, the goal for the HIV research community continues to be to develop new treatments to target the virus and any resistant strains that might develop, and also to improve side effects, adherence and education, simplify drug regimens and reduce costs. In addition, the ultimate aim should be the complete eradication of HIV from an infected immune system.

Annals of AIDS and HIV Infections publishes Original research articles like, clinical trials, Reviews, Case report, Editorials, Letter to the editor, Short communication, Opinion, Book reviews and other special featured articles related to the field of HIV/AIDS & Clinical Research. With a large international editorial board of experts who are leaders in their fields, HIRS aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.

Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published. Papers are accepted on a worldwide basis. HIRS welcomes direct submissions of manuscripts from authors.

You are welcome to submit your work to or at

Open Access Policy: This journal is an open access journal which provides immediate, worldwide, boundary free access to the full content of every distributed article without charging readers or their institutions for access. Readers are given authorization to read, circulate, copy, print, download, search, or link to the full texts of all articles in HIRS.

Editorial Board

Below are our esteemed editorial board members

Dr. Xiaoling Xuei, Ph.D.

The Center for Medical Genomics
Department of Medical and Molecular Genetics
Indiana University School of Medicine
980 W. Walnut St.
Walther Hall, Rm 418
Indianapolis, IN 46202

Dr. Nondumiso B Q Ncube

Lecturer and Clinical Researcher UWC
School of Public Health,
University of the Western Cape,
South Africa

Dr. Abhay Bhausaheb Solunke

Assistant Professor
Department of Biological Sciences,
Gauhati University,
Guwahati, Assam


Medical director – Synevo Bulgaria
Lozenetz University Hospital
1 Kozyak Str, 1407 Sofia

Dr J-F

Lecturer in Human Development and Learning
Big Data Consultant/Management
Faculty of Education
College of Arts, Law and Education,
University of Tasmania, Level 2, Building A, A230b

Dr. Fulvio Erba

Aggregate professor of Biochemistry
Department of Clinical Science and Traslational Medicine
University of Tor Vergata
Rome – Italy

Dr. Madhulika A. Mistry

Assistant Professor
Dept. of Microbiology
PDU Medical College,
Rajkot, Gujarat

Dr. Suayip Yuzbasi

Associate Professor
Department of Mathematics
Faculty of Science
Akdeniz University
Tr-07058, Atalya,

Dr. Deepak Pandey

ICSSR- Post Doctoral Fellow
Department of Psychology
Pt. Sundarlal Sharma (Open) University Chhattisgarh,
Bilaspur, Chhattisgarh, India

Dr. Fernandos K. Ongolly

Social Scientist
Kenya Medical Research Institute
University of Nairobi C4D lab

Published Articles

Submit Manuscript

Please submit your manuscript to


JCRM journal has received impact factor of 1.02 for its 2018 volume.